Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2016 participants

Study Classification

OBSERVATIONAL

Study Start Date

2005-05-31

Study Completion Date

2015-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is conducted in Japan. The aim of this study is to collect information about the efficacy and safety of Norditropin® (somatropin) in the long-term treatment of short stature with GHD (Growth Hormone Deficiency) where epiphysial discs are not closed and short stature with Turner Syndrome where epiphysial discs are not closed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

NCT01110928

Foetal Growth Problem Small for Gestational Age

COMPLETED

Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

NCT01109017

Growth Hormone Disorder Adult Growth Hormone Deficiency

COMPLETED

Special Survey for Long Term Application

NCT01516229

Genetic Disorder Achondroplasia

COMPLETED

Observational Prospective Study on Patients Treated With Norditropin®

NCT00960128

Growth Hormone Disorder Growth Hormone Deficiency in Children Adult Growth Hormone Deficiency +7 more

COMPLETED

Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children

NCT00102817

Growth Hormone Disorder Pituitary Dwarfism

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Growth Hormone Disorder Growth Hormone Deficiency in Children Genetic Disorder Turner Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Somatropin

somatropin

Intervention Type DRUG

Collection of safety and efficacy data in connection with use of somatropin (Norditropin®) in daily clinical practice.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

somatropin

Collection of safety and efficacy data in connection with use of somatropin (Norditropin®) in daily clinical practice.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Growth hormone deficiency or short stature due to Turner Syndrome where the epiphyseal discs are not closed

Exclusion Criteria

* Diabetic
* Patients with malignant tumors
* Women who are either pregnant or likely to be pregnant
* Known or suspected allergy to study product(s) or related products

Eligible Sex

ALL

Accepts Healthy Volunteers

No